HireRight Holdings Corp (HRT) – Major News
-
HireRight Holdings Corp (HRT) Tops Q3 EPS by 2c ; Offers Guidance
-
HireRight Holdings Corp (HRT) Tops Q2 EPS by 1c
-
HireRight Holdings Corp (HRT) Misses Q1 EPS by 9c; Offers FY23 Guidance
-
HireRight Holdings Corp (HRT) Tops Q4 EPS by 13c; Offers Guidance
-
HireRight Holdings Corp (HRT) Tops Q2 EPS by 19c; Guides Higher
-
HireRight Holdings Corp (HRT) Tops Q1 EPS by 18c, Offers Guidance
-
HireRight Holdings Corp (HRT) Tops Q4 EPS by 25c, Guidance Tops Consensus
-
HireRight Holdings Corp (HRT) Reports Q3 EPS of $0.13, Offers Guidance
-
HireRight (HRT) IPO Opens 5% Lower, Valuing Co. at ~$1.4 Billion
-
HireRight (HRT) IPO: 9 Things to Know About the Upcoming Offering
-
Arrhythmia Research Technology (HRT) Reports Q2 EPS of $0.02
-
Arrhythmia Research Technology (HRT) Posts Surprise Q3 Loss
-
Arrhythmia Research Technology (HRT) Reports Q1 EPS of $0.04
-
Arrhythmia Research Technology (HRT) Swings to Q4 Profit
-
Arrhythmia Research Technology (HRT) Reports Q1 EPS of $0.09
-
Arrhythmia Research Technology (HRT) Reports Q4 Loss of $0.03/Share
-
Arrhythmia Research Technology (HRT) Q2 Loss Widens to $1.06/Share
-
Arrhythmia Research (HRT) Sees Wider Q2 Loss
-
Arrhythmia Research (HRT) Appoints Michael Gunter as Interim CEO
-
Arrhythmia Research Technology (HRT) Widens Q2 Loss to 37c/Share
-
Arrhythmia Research (HRT) Q1 Profit Slips Amid Stronger Revs
-
Arrhythmia Research (HRT) Posts Q3 EPS of $0.04, In-Line Y/Y
-
Arrhythmia Research Technology (HRT) Reports Stronger Q2 Results
-
Arrhythmia Research Tech (HRT) Swings to Q4 Profit of $0.04; Revs Up Y/Y
Back to HRT Stock Lookup